NCT02933866View on ClinicalTrials.gov

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

March 11, 2016

Primary Completion Date

November 16, 2016

Study Completion Date

September 29, 2017

Conditions
Scalp Psoriasis
Interventions
DRUG

DSXS topical

topical treatment

DRUG

Vehicle topical

topical treatment

Trial Locations (1)

10532

Taro Pharmaceuticals USA, Inc., Hawthorne

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02933866 - Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis | Biotech Hunter | Biotech Hunter